Skip to main content
Premium Trial:

Request an Annual Quote

Golden Rice Soon?

Officials in Bangladesh are poised to approve the sale of "golden rice," which book author Ed Regis argues in an opinion piece in the Washington Post could save children from blindness and death.

Golden rice was developed to contain higher levels of beta carotene to help prevent vitamin A deficiency, which causes blindness and death largely among children in the developing world, he adds, but its use ran into not only opposition from activists against genetically modified food, but also opposition from the regulatory agencies of countries it was intended to help.

In particular, Regis, who has written a book on golden rice, says the United Nations-sponsored Cartagena Protocol, which sought to protect biological diversity from unknown effects of GMOs, hamstrung the use of golden rice. He argues that it led to "restrictions on a given GMO in the absence of any actual proof that it would cause harm" and prevented children from getting needed nutrients.

He adds that if Bangladesh does approve golden rice and if it does save children's sight and lives, then regulatory agencies and others " will have a lot of explaining to do."

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.